Lazabemide hydrate

CAS : 103878-84-8

Ref. 3D-DEA87884

Informations sur le produit

• Nom: Lazabemide hydrate
• Synonymes: 2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro-, 6-Chloropyridine-N-(3-hydroxypropyl)-2-carbonylamide, Ccris 7301, Lazabemide [USAN:INN], N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide, N-(2-Aminoethyl)-5-chloropicolinamide, N-(2-aminoethyl)-5-chloropyridine-2-carboxamide, Ro 19-6327/000, Unii-420Hd787N9

Description

Lazabemide hydrate is a drug that inhibits monoamine oxidase type A and B (MAO-A and MAO-B) enzymes, which are responsible for the degradation of dopamine, serotonin, and norepinephrine. It has been shown to be effective in treating bowel disease. Lazabemide hydrate can also be used to prevent or treat depression, Parkinson's disease, and other neurological disorders. Lazabemide hydrate is approved for use in the United States under the trade name Rasagiline Mesylate.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 199.64 g/mol
• Formule: C₈H₁₀ClN₃O·xH₂O
• Degré de pureté: Min. 95%